RT-PCR Respiratory Panel 1

About GeneProof

GeneProof is a Brno-based molecular diagnostics company with a comprehensive portfolio focused on infectious diseases (bloodborne, respiratory, STIs, neuroinfections) and genetic conditions like thrombotic mutations. Its core offerings include PCR test kits, extraction reagents, and the myCROBE™ fully automated system, all designed for clinical laboratory use. The 2022 merger with ALPCO significantly expanded its global commercial reach and operational scale, positioning it as a competitive player in the IVD market with a strong emphasis on regulatory compliance (IVDR). The company targets healthcare professionals through a worldwide distributor network.

Therapeutic Areas